NINGBO INNO PHARMCHEM CO.,LTD. is a prominent player in the supply of high-quality chemical intermediates that are essential for the development of advanced pharmaceuticals. Among these crucial compounds is (1R,2R)-(-)-1,2-Diaminocyclohexane, identified by its CAS number 20439-47-8. This chiral diamine is an indispensable building block in the synthesis of Oxaliplatin, a cornerstone platinum-based antineoplastic agent widely utilized in chemotherapy regimens, particularly for advanced colorectal cancer.

The intricate process of synthesizing effective cancer drugs demands intermediates of exceptional purity and precise molecular structure. (1R,2R)-(-)-1,2-Diaminocyclohexane, appearing as a white crystalline powder, meets these stringent requirements. Its specific stereochemistry is critical for the biological activity of Oxaliplatin, influencing its ability to interact with DNA and induce cancer cell death. The consistent availability of this intermediate from reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. ensures the uninterrupted production of this life-saving medication, thereby supporting global efforts in cancer treatment.

The demand for such specialized pharmaceutical intermediates is growing as cancer research progresses and new therapeutic strategies are developed. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting this demand by providing materials that adhere to the highest quality standards. By focusing on critical 1R,2R-Diaminocyclohexane Oxaliplatin intermediate sourcing, the company contributes significantly to the pharmaceutical industry's ability to deliver effective treatments. Understanding the importance of CAS 20439-47-8 in the global pharmaceutical supply chain highlights the foundational role of chemical manufacturers in advancing healthcare outcomes.